MicroRNAs are important regulators of drug resistance in colorectal cancer

Yang Zhang, Jing Wang

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Despite of continuous development of cancer treatment over the past decades, drug resistance is still one of the major hurdles of effective therapy for advanced colorectal cancer (CRC) worldwide and the understanding of its underlying mechanisms remains limited. Data which have emerged suggests that many microRNAs (miRNAs) may contribute to drug resistance in CRC. Major findings on miRNA functions in drug resistance of CRC are systemically reviewed here, with the goal of providing new updates to broaden our comprehension of its mechanisms and evidence to utilize miRNAs as potential therapeutic targets for CRC treatment.

Original languageEnglish (US)
Pages (from-to)929-938
Number of pages10
JournalBiological Chemistry
Volume398
Issue number8
DOIs
StatePublished - Jul 26 2017

Fingerprint

MicroRNAs
Drug Resistance
Colorectal Neoplasms
Oncology
Pharmaceutical Preparations
Therapeutics
Neoplasms

Keywords

  • apoptosis
  • chemoresistance
  • chemotherapy
  • colorectal cancer
  • drug resistance
  • miRNAs

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Clinical Biochemistry

Cite this

MicroRNAs are important regulators of drug resistance in colorectal cancer. / Zhang, Yang; Wang, Jing.

In: Biological Chemistry, Vol. 398, No. 8, 26.07.2017, p. 929-938.

Research output: Contribution to journalReview article

Zhang, Yang ; Wang, Jing. / MicroRNAs are important regulators of drug resistance in colorectal cancer. In: Biological Chemistry. 2017 ; Vol. 398, No. 8. pp. 929-938.
@article{b7962c23cc9c41b483fb6cde9a31b8ce,
title = "MicroRNAs are important regulators of drug resistance in colorectal cancer",
abstract = "Despite of continuous development of cancer treatment over the past decades, drug resistance is still one of the major hurdles of effective therapy for advanced colorectal cancer (CRC) worldwide and the understanding of its underlying mechanisms remains limited. Data which have emerged suggests that many microRNAs (miRNAs) may contribute to drug resistance in CRC. Major findings on miRNA functions in drug resistance of CRC are systemically reviewed here, with the goal of providing new updates to broaden our comprehension of its mechanisms and evidence to utilize miRNAs as potential therapeutic targets for CRC treatment.",
keywords = "apoptosis, chemoresistance, chemotherapy, colorectal cancer, drug resistance, miRNAs",
author = "Yang Zhang and Jing Wang",
year = "2017",
month = "7",
day = "26",
doi = "10.1515/hsz-2016-0308",
language = "English (US)",
volume = "398",
pages = "929--938",
journal = "Biological Chemistry",
issn = "1431-6730",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "8",

}

TY - JOUR

T1 - MicroRNAs are important regulators of drug resistance in colorectal cancer

AU - Zhang, Yang

AU - Wang, Jing

PY - 2017/7/26

Y1 - 2017/7/26

N2 - Despite of continuous development of cancer treatment over the past decades, drug resistance is still one of the major hurdles of effective therapy for advanced colorectal cancer (CRC) worldwide and the understanding of its underlying mechanisms remains limited. Data which have emerged suggests that many microRNAs (miRNAs) may contribute to drug resistance in CRC. Major findings on miRNA functions in drug resistance of CRC are systemically reviewed here, with the goal of providing new updates to broaden our comprehension of its mechanisms and evidence to utilize miRNAs as potential therapeutic targets for CRC treatment.

AB - Despite of continuous development of cancer treatment over the past decades, drug resistance is still one of the major hurdles of effective therapy for advanced colorectal cancer (CRC) worldwide and the understanding of its underlying mechanisms remains limited. Data which have emerged suggests that many microRNAs (miRNAs) may contribute to drug resistance in CRC. Major findings on miRNA functions in drug resistance of CRC are systemically reviewed here, with the goal of providing new updates to broaden our comprehension of its mechanisms and evidence to utilize miRNAs as potential therapeutic targets for CRC treatment.

KW - apoptosis

KW - chemoresistance

KW - chemotherapy

KW - colorectal cancer

KW - drug resistance

KW - miRNAs

UR - http://www.scopus.com/inward/record.url?scp=85023184416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023184416&partnerID=8YFLogxK

U2 - 10.1515/hsz-2016-0308

DO - 10.1515/hsz-2016-0308

M3 - Review article

C2 - 28095367

AN - SCOPUS:85023184416

VL - 398

SP - 929

EP - 938

JO - Biological Chemistry

JF - Biological Chemistry

SN - 1431-6730

IS - 8

ER -